Informing a clinical trial of a 1-week radiotherapy schedule
Categories: Patient or Loved One
Become a patient advocate and help to inform a clinical trial looking at carrying out radiotherapy for breast cancer in 1 week instead of 3
What’s the study about?
Last year, we shared an opportunity for you to get involved in shaping a clinical trial called FAST-FORWARD Boost. The trial is looking to test whether people with breast cancer can have radiotherapy treatment in 1 week instead of 3.
It will launch in 2025 and involve 4830 people with breast cancer from over 40 NHS hospitals, running for 8.5 years.
The researchers are now wanting to recruit patient advocates who can bring a range of perspectives and experiences to the set-up and delivery of the trial.
Who can take part?
The researchers are looking for 1 person with advocacy experience to join the team as the PPI Lead.
They’re looking for a number of people to join the TMG and advisory panel, with no advocacy experience needed.
The trial aims to improve the assessment of skin reactions in people with different skin tones. And assess the impact of daily travel for treatment for patients from all locations. So they’re keen to include people from diverse demographic backgrounds and geographical locations as
They’d also like to hear from people with caring responsibilities or who have had to work during their radiotherapy treatment, because they know that the duration of treatment and side-effect management can be difficult in these contexts.
Why do you want me to be involved?
People who’ve had breast cancer and received radiotherapy have already helped to design FAST-Forward Boost. Now. The researchers need your voice to continue this work.
By hearing your experiences, they can ensure that all patients enrolled in the FAST-Forward Boost trial are treated with their quality of experience being paramount and, in turn, improve the quality of our research.
What will you ask me to do?
The PPI Lead role will be required to join meetings during normal office hours and is funded for 1 day per month (payment by honorarium). All meetings will have the option to attend virtually (online).
TMG and Advisory panel members will be required on an ad hoc basis (up to 4 times per year) and reimbursement for time and expenses will be provided.
All roles are for the long term. Please see the full role advertisement for details.
How do I get involved?
To find out more information about the trial or any of the individual roles, you can read the full role advertisement. You can also email one of the team members fastforwardboost-icrctsu@icr.ac.uk.
If you’d like to apply for any of the roles mentioned, please submit a 1-page document outlining your experience and interest in the PPI role by Friday 20th September.
All applications will be reviewed and suitable candidates will be invited for an informal interview with the trial team to further discuss responsibilities and answer any questions you may have.
To apply, or if you would like more information or an informal chat about this study, please email: fastforwardboost-icrctsu@icr.ac.uk